RxDoctor Payments DataLook up a doctor →

Seth Miller, PA

Physician Assistant · Shreveport, LANPI 1346521945

Payments from drug & device makers

$15,930in general payments, 2019–2025

Across 941 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$3K
  • Johnson & Johnson$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Pfizer$777
  • Sanofi$679
  • plus $4K from 29 others

What the payments were for

  • Food & beverage$15,74099%
  • Education$1901%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,930 in reported general payments places this provider in the 95th percentile of 1,246 physician assistant providers in Louisiana.

See all physician assistant providers in Louisiana

Medicare billing

Part B allowed, 2024
$119,728
Medicare patients
721
Services billed
1,068

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide23$22,492
Mesalamine15$8,938
MotegrityPrucalopride Succinate14$7,291
Colesevelam Hcl18$4,581
Budesonide DrBudesonide23$4,099
Esomeprazole Magnesium112$3,456
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg110$2,472
Colestipol Hcl23$2,281
Lubiprostone19$1,529
Pantoprazole Sodium100$1,210
Sucralfate51$1,119
Omeprazole49$684
Baclofen63$595
Mirtazapine46$387
Dicyclomine Hcl15$351

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$3,853$22,49223 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$1,247$7,29114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,246 physician assistant providers in Louisiana.

Other physician assistant in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →